Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

GRITSTONE BIO, INC.

(GRTS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Gritstone Oncology Expands Vaccine Agreement With Coalition for Epidemic Preparedness Innovations to Deal With Omicron

12/06/2021 | 07:54am EST


ę MT Newswires 2021
All news about GRITSTONE BIO, INC.
01/13Gritstone Starts Enrollment in Phase 2/3 Trial of Colorectal Cancer Vaccine
MT
01/13Gritstone Announces First Patient Enrolled for Phase 2/3 Trial Evaluating Individualize..
AQ
01/13Gritstone Announces First Patient Enrolled for Phase 2/3 Trial Evaluating Individualize..
CI
01/10GRITSTONE BIO, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
01/06UNIVERSITY OF MANCHESTER : Early data for multivariant COVID-19 vaccine booster shows prom..
AQ
01/05GRITSTONE BIO : Announces Positive Clinical Results from First Cohort of a Phase 1 Study (..
PU
01/04GRITSTONE BIO, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
01/04Gritstone Reports Positive Data From Study of Second-Generation COVID-19 Vaccine; Share..
MT
01/04Gritstone Announces Positive Clinical Results from First Cohort of a Phase 1 Study (COR..
AQ
01/04Gritstone Bio, Inc. Announces Positive Clinical Results from First Cohort of A Phase 1 ..
CI
More news
Analyst Recommendations on GRITSTONE BIO, INC.
More recommendations
Financials (USD)
Sales 2021 48,0 M - -
Net income 2021 -73,9 M - -
Net cash 2021 80,4 M - -
P/E ratio 2021 -5,79x
Yield 2021 -
Capitalization 425 M 425 M -
EV / Sales 2021 7,17x
EV / Sales 2022 16,2x
Nbr of Employees 188
Free-Float -
Chart GRITSTONE BIO, INC.
Duration : Period :
Gritstone bio, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GRITSTONE BIO, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 6,25 $
Average target price 19,67 $
Spread / Average Target 215%
EPS Revisions
Managers and Directors
Andrew R. Allen President, Chief Executive Officer & Director
Vassiliki Celia Economides Chief Financial Officer & Executive Vice President
Elaine V. Jones Chairman
Karin Jooss Head-Research & Development
RaphaŰl Rousseau Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
GRITSTONE BIO, INC.-51.40%425
CSL LIMITED-5.06%95 466
WUXI BIOLOGICS (CAYMAN) INC.-0.27%49 958
SAMSUNG BIOLOGICS CO.,LTD.-5.87%47 262
ALEXION PHARMACEUTICALS, INC.0.00%40 336
BIOGEN INC.-0.26%35 151